An effective treatment for aphthous stomatitis is not still available and its treatment consists only of therapeutic measures to suppress its symptoms. We report a case of a 60-year caucasian woman presented a 16-year history of episodes of multiple major recurrent ulcers in the oral mucosa. Topical application of Oralmedic ® caused an improvement of pain, discomfort and healing of the aphthous ulcer. No adverse events or side effects were recorded. Oralmedic® is an effective topical device for the major aphthous ulcers treatment.
Introduction
Aphthae are common oral lesions that a ect approximately 10% to 20% of the population.
e etiology of aphthous stomatitis is unknown but according to an increasing evidence, its development has an immunogenic process that causes the ulceration of the involved oral mucosa. Aphthous ulcers are usually classi ed into three di erent types: minor, herpetiform and major [1, 2] . Minor aphthae are generally located on labial or buccal mucosa, the so palate, the oor of the mouth, the ventral surface and the border of the tongue. ey can be singular or multiple and tend to be small (less than 1 cm in diameter) and shallow [2] . Herpetiform aphthae are rare and their clinical aspect is similar to the Herpes virus vesciculae. Major aphthae are similar to minor aphthae but they are larger (may reach over 1 cm in diameter) and cause a deeper ulceration. is subtype makes up about 10% of all cases of aphthous stomatitis. Major aphthous ulceration usually a ects non keratinized mucosal surfaces, but less commonly keratinized mucosa may also be involved. Pariadenitis mucosa necrotica recurrens or Sutton disease is characterized by the involvement of minor salivary in the oral mucosal destructive process that causes the ulcers. Major aphthous ulcerations can persist for several days or weeks and o en heal with scarring. e pain associated with major aphthae lesions can a ect eating, speaking and oral hygiene practices [3] . ere have been many attempts over the years to nd an e ective treatment for aphthous stomatitis, but the etiology of this stomatitis remains unknown and its treatment consists only of therapeutic measures to suppress its symptoms rather than bringing about a de nitive cure.
e therapeutic choice depends on the severity of the disease which is measured by the frequency of ulcers recurrence, the number of ulcers, their location, duration and the level of associated orofacial pain [4] . Most of major aphthosis cases are characterized by pain, fever, dysphagia and require a systemic therapy. Several systemic drugs have been used to treat major aphthosis, including systemic corticosteroids, dapsone, colchicine, thalidomide, pentoxifylline, low-dose interferon-α and levamisole [5] . e use of systemic corticosteroids and immunomodulating agents has been the mainstay of treatment for major aphthae. Intralesional steroid injections, containing betamethasone dipropionate and betamethasone disodium phosphate, combined with levamisole therapy may successfully treat the large ulcers associated with major aphthosis [6] . A recent Cochrane review on the systemic treatment for the recurrent aphthous stomatitis concluded that "no single treatment was found to be e ective and therefore the results remain inconclusive in regard to the best systemic intervention for recurrent aphthous stomatitis" [7] .
e following report describes a case of major aphthosis involving the oral mucosa successfully treated with topical applications of Oralmedic ® .
Case Report
A 60-year-old caucasian woman presented a 16-year history of episodes of multiple major recurrent ulcers in the oral mucosa (non keratinized mucosa). During the patient's anamnesis, she reported having had these episodes since the rst pregnancy and having already been treated with corticosteroids, without success. Clinical examination revealed a symptomatic ulcer with a perilesional erythematous halos covered with a pseudomembrane and located in the oor of the mouth mucosa, exceeding 10 mm in diameter (Figure 1) . A clinical diagnosis of major aphthous ulcer was made on the basis of the history and the clinical examinations. e other aspects both of the patient's medical history and the family medical history were insigni cant. Laboratory tests including a blood count analysis were performed to determine the levels of folic acid, iron, ferritin, as well as vitamins B2, B6 and B12. All the results were normal. e patient was subjected to a therapeutic regimen consisting of daily topical application of Oralmedic® (Ceuta Healthcare, Hill House, Richmond Hill, Bournemouth, UK). A er bu ering and drying the ulcerative area, approximately 0.2 ml of the cauterizing solution was delivered from a hollow sha of a cotton wool swab to the tip which was then placed upon the ulcer (in situ) for 10 seconds (Figure 2) .
A erwards the patient rinsed and dried the treated area. e patient was subjected to four applications with Oralmedic® once a week. In the subsequent follow-up visits there was an improvement of pain, discomfort and healing of the aphthous ulcer (Figure 3 and 4) . No adverse events or side e ects were recorded. 
Discussion
Because of its uncertain etiology and variegate clinical presentation, aphthous stomatitis remains a challenge for the specialists in oral pathology and medicine. B group vitamins de ciency or impairment of iron metabolism may be the predisposing factor in the pathogenic cascade but only a restrict number of patients show a vitamin or iron de cit. In the reported case, the patients was in good health and the aphthous ulcer was de ned as "idiopathic". Treatment of aphthous ulcers is fundamentally symptomatic: it is aimed to reduce the severity and duration of the pain and decrease the frequency of the relapse. e lack of an e cacious and de nitive prophylactic protocol has led to the development of several treatments that use di erent drugs, antibacterial agents (eg, minocycline, tetracycline, cephalexin), anti-acidic agents (eg, sucralfate) and antineoplastics (eg, thalidomide) [8] [9] [10] . Anti-in ammatory and immunomodulatory agents such as clofazimine, thalidomide, pentoxifylline, colchicine, levamisole, azathioprine, amlexanox and steroids have been administered with varying clinical bene ts [11] . e active principle of Oralmedic ® utilizes the same technology commercialized for the non-surgical treatment of the dental plaque (HybenX ® ): it is a desiccant liquid and its application to plaque bio lm instantly causes rapid absorption of water (strong hygroscopic properties), which leads to the precipitation and collapse of organic material. e Oralmedic ® solution comprises a concentrated aqueous mixture of free sulphate and sulphonated aromatics, speci cally hydroxybenzenesulphonic acid, hydroxymethoxybenzene suphonic acid and suphuric acid. e hydrozybenzenes are keratolytic, whereas the sulphonate groups and sulphuric acid are hygrposcopic and denaturing. e use of Oralmedic ® in the treatment of aphtae was rst reported by Porter et al. [12] . ey examined the potential bene ts of HybenX in a prospective randomized trial. eir results revealed that when compared with a device designed to protect areas of oral ulceration, local application of HybenX signi cantly reduced the pain of RAS a er 2 days. Both HybenX and the control device caused a reduction in unchallenged pain scores between days 1 and 4, but the reduction by HybenX was always greater than that of the control device. Denaturation, precipitation and coagulation of the tissue debris on the aphthous ulcer surface and the creation of a protective layer of is protective surface debris is resorbed during the "restitutio ad integrum" process [13] .
A recent study shows that the topical treatments for recurrent aphthous stomatitis are not e cacious in the improvement of quality of life in the a ected patients and only colchicine seems to be e ective in the management of signs and symptoms related to aphthous ulcerations [14] . However, the topical treatment o ers numerous advantages related to the scarcity of side e ects, a more tolerability and its easy use in the delimited area to treat.
Conclusion
In conclusion, Oralmedic ® is an e ective topical device for the major aphthous ulcers treatment. Alternative treatment options are required and the bene ts and harms of using topical Oralmedic ® in people with aphthous stomatitis need a thorough evaluation in properly designed controlled studies.
